- Home
- SMWB vs PSNL Comparison
SMWB vs PSNL Comparison
Compare SMWB & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMWB
- PSNL
- Stock Information
- Founded
- SMWB 2007
- PSNL 2011
- Country
- SMWB Israel
- PSNL United States
- Employees
- SMWB N/A
- PSNL N/A
- Industry
- SMWB Computer Software: Programming Data Processing
- PSNL Medical Specialities
- Sector
- SMWB Technology
- PSNL Health Care
- Exchange
- SMWB Nasdaq
- PSNL Nasdaq
- Market Cap
- SMWB 747.7M
- PSNL 854.8M
- IPO Year
- SMWB 2021
- PSNL 2019
- Fundamental
- Price
- SMWB $7.82
- PSNL $10.68
- Analyst Decision
- SMWB Strong Buy
- PSNL Strong Buy
- Analyst Count
- SMWB 8
- PSNL 7
- Target Price
- SMWB $14.88
- PSNL $10.43
- AVG Volume (30 Days)
- SMWB 390.1K
- PSNL 1.8M
- Earning Date
- SMWB 11-11-2025
- PSNL 11-04-2025
- Dividend Yield
- SMWB N/A
- PSNL N/A
- EPS Growth
- SMWB N/A
- PSNL N/A
- EPS
- SMWB N/A
- PSNL N/A
- Revenue
- SMWB $275,429,000.00
- PSNL $69,103,000.00
- Revenue This Year
- SMWB $16.98
- PSNL N/A
- Revenue Next Year
- SMWB $14.91
- PSNL $29.83
- P/E Ratio
- SMWB N/A
- PSNL N/A
- Revenue Growth
- SMWB 14.25
- PSNL N/A
- 52 Week Low
- SMWB $6.36
- PSNL $2.83
- 52 Week High
- SMWB $17.64
- PSNL $11.40
- Technical
- Relative Strength Index (RSI)
- SMWB 45.94
- PSNL 64.67
- Support Level
- SMWB $7.14
- PSNL $9.41
- Resistance Level
- SMWB $8.20
- PSNL $9.89
- Average True Range (ATR)
- SMWB 0.44
- PSNL 0.94
- MACD
- SMWB 0.02
- PSNL 0.29
- Stochastic Oscillator
- SMWB 47.19
- PSNL 84.19
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.